Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2014
04/01/2014US8685457 Pharmaceutical formulation for the production of rapidly disintegrating tablets
04/01/2014US8685455 Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
04/01/2014US8685454 Lubricating composition
04/01/2014US8685452 Pharmaceutical composition
04/01/2014US8685451 Triple combination release multi-layered tablet
04/01/2014US8685450 Dual drug dosage forms with improved separation of drugs
04/01/2014US8685449 Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
04/01/2014US8685448 Pharmaceutical solid dosage form
04/01/2014US8685447 Misuse preventative, controlled release formulation
04/01/2014US8685446 Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients
04/01/2014US8685445 Enteric composition for the manufacture of soft capsule wall
04/01/2014US8685444 Sequestering subunit and related compositions and methods
04/01/2014US8685443 Sequestering subunit and related compositions and methods
04/01/2014US8685442 Capsules containing high doses of levodopa for pulmonary use
04/01/2014US8685441 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
04/01/2014US8685440 Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same
04/01/2014US8685437 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
04/01/2014US8685436 Use of hydroxyflavanones for masking bitter taste
04/01/2014US8685435 Extended release biodegradable ocular implants
04/01/2014US8685429 Shaped bodies and methods for their production and use
04/01/2014US8685428 Therapeutic composition and a method of coating implantable medical devices
04/01/2014US8685427 Controlled drug delivery
04/01/2014US8685426 Methods for making biocompatible, implantable, substantially sericin free silk fabric
04/01/2014US8685418 Cyclohexylamines
04/01/2014US8685417 Polymer encapsulation and/or binding
04/01/2014US8685382 Temperature sensitive polymers
04/01/2014US8685374 EDTA containing compositions and uses thereof
04/01/2014US8685373 Mucosal or cutaneous medicinal or hygiene system
04/01/2014US8685002 Data storage for an infusion pump system
04/01/2014US8684996 Method and apparatus for setting a basal rate profile for an insulin pump
04/01/2014US8684739 Durable film coating compositions having sustained slow-release capability, and methods of use therefor
04/01/2014CA2692606C Inhalable solid amorphous particles comprising tiotropiium bromide and a co-solid
04/01/2014CA2652712C Stabilized pharmaceutical compositions comprising fesoterodine
04/01/2014CA2631872C Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
04/01/2014CA2629599C Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution
04/01/2014CA2624372C Microparticles with modified release of at least one active principle and oral galenic form comprising same
04/01/2014CA2569590C Drug having regulatory cell ligand contained in liposome
04/01/2014CA2524184C Microbial cellulose wound dressing comprising phmb
04/01/2014CA2510196C Intracutaneous injection
04/01/2014CA2423122C Closure of bacterial ghosts
03/2014
03/28/2014CA2828588A1 Patch preparation containing amine oxide
03/27/2014WO2014047509A1 Nanocomposites for imaging and drug delivery
03/27/2014WO2014047497A1 Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
03/27/2014WO2014047493A1 Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate and protein
03/27/2014WO2014047477A2 Multilayer biodegradable microparticles for sustained release of therapeutic agents
03/27/2014WO2014047476A1 Compositions and methods for improving health in animals
03/27/2014WO2014047439A1 Biodegradable microcapsules containing filling material
03/27/2014WO2014047427A2 Substituted benzofuran, benzothiophene and indole mcl-1 inhibitors
03/27/2014WO2014047324A1 Fiber spheres
03/27/2014WO2014047323A1 Methods for treating post-traumatic stress disorder
03/27/2014WO2014047321A1 Compositions and methods for increasing human growth hormone levels
03/27/2014WO2014047320A1 Methods for improving linear growth response in children
03/27/2014WO2014047314A1 Methods for improving thyroid function in healthy humans
03/27/2014WO2014047305A1 Methods and compositions for increasing growth hormones
03/27/2014WO2014047221A1 Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium
03/27/2014WO2014047212A1 Compositions and methods comprising oxadiazole derivatives
03/27/2014WO2014047191A1 Transdermal drug delivery device
03/27/2014WO2014047169A1 Topical compositions comprising no and phosphatidycholine for cancer treatment
03/27/2014WO2014047167A1 Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
03/27/2014WO2014047166A1 Techniques and systems for the treatment of neuropathic pain
03/27/2014WO2014047158A1 Methods and compositions for muscular or neuromuscular diseases
03/27/2014WO2014047153A1 Treatment and prevention of learning and memory disorders
03/27/2014WO2014047150A2 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
03/27/2014WO2014047148A1 Methods and systems for treatment of inflammatory diseases with nitric oxide
03/27/2014WO2014047144A1 Treatment of skin and soft tissue infection with nitric oxide
03/27/2014WO2014047140A1 Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
03/27/2014WO2014047116A1 Encapsulating liposomes
03/27/2014WO2014047007A1 Suspension pharmaceutical formulations comprising low melting propionic acid derivative particles
03/27/2014WO2014047005A1 Sustained release oral dosage forms comprising low melting propionic acid derivative particles
03/27/2014WO2014047001A1 Low melting propionic acid derivative particles for use in oral dosage forms
03/27/2014WO2014046631A1 CONTROLED DRUG DELIVERY SYSTEMS FOR ANTI-TNF-α
03/27/2014WO2014046472A1 Medicine having improved rivastigmine stability
03/27/2014WO2014046415A1 Method for preparing in situ-formed hydrogel using enzyme-immobilized support, and biomedical use thereof
03/27/2014WO2014046312A1 Oral preparation and method for producing the same
03/27/2014WO2014046243A1 Support body for transdermal patch or transdermal preparation, and transdermal patch and transdermal preparation using same
03/27/2014WO2014046191A1 Local-anesthetic long-lasting sustained-release liposome preparation
03/27/2014WO2014046129A1 Pharmaceutical composition for oral administration with improved elution and/or absorbency
03/27/2014WO2014046065A1 Advanced heart failure treatment material as myocardial/cardiovascular regeneration device
03/27/2014WO2014046035A1 Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition
03/27/2014WO2014045213A1 Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein
03/27/2014WO2014045081A1 Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein
03/27/2014WO2014044907A1 A method for coating pharmaceutical substrates
03/27/2014WO2014044896A1 Orodispersible pharmaceutical composition of melatonin
03/27/2014WO2014044894A1 Controlled-relase formulation
03/27/2014WO2014044794A2 Pharmaceutical composition
03/27/2014WO2014044690A1 Improved vaccines
03/27/2014WO2014016848A3 Solid forms of tyrosine kinase inhibitors, process for the preparation and their pharmaceutical composition thereof
03/27/2014WO2013151744A9 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion
03/27/2014WO2013130669A8 Pharmaceutical composition and administration thereof
03/27/2014WO2013054298A3 Modified polyethylene glycols and their supramolecular complexes with biologically active macromolecules
03/27/2014WO2013036383A8 Oral delivery for hemoglobin based oxygen carriers
03/27/2014WO2012018643A3 Compositions for proliferation of cells and related methods
03/27/2014US20140088202 Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
03/27/2014US20140088195 Topical ketoprofen composition
03/27/2014US20140088185 Method of treating digestive upsets by buccal administration of botanical derivatives
03/27/2014US20140088181 Taxane Pro-Emulsion Formulations and Methods Making and Using the Same
03/27/2014US20140088166 Process of making and using pharmaceutical formulations of antineoplastic agents
03/27/2014US20140088135 Immunosuppressive macrolide powder for oral suspension
03/27/2014US20140088131 Implantable Polymeric Device for Sustained Release of Buprenorphine
03/27/2014US20140088108 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitiors
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 2991